Compare MCHP & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MCHP | WAT |
|---|---|---|
| Founded | 1989 | 1958 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.7B | 42.2B |
| IPO Year | 2004 | 1996 |
| Metric | MCHP | WAT |
|---|---|---|
| Price | $76.31 | $455.11 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 26 | 23 |
| Target Price | $106.52 | ★ $465.86 |
| AVG Volume (30 Days) | ★ 8.5M | 709.9K |
| Earning Date | 11-05-2026 | 11-03-2026 |
| Dividend Yield | ★ 2.46% | N/A |
| EPS Growth | ★ 2300.00 | 0.47 |
| EPS | ★ 0.37 | N/A |
| Revenue | ★ $5,349,500,000.00 | N/A |
| Revenue This Year | $35.88 | $103.96 |
| Revenue Next Year | $16.34 | $10.44 |
| P/E Ratio | $199.89 | ★ N/A |
| Revenue Growth | ★ 34.38 | N/A |
| 52 Week Low | $48.52 | $282.77 |
| 52 Week High | $105.91 | $465.36 |
| Indicator | MCHP | WAT |
|---|---|---|
| Relative Strength Index (RSI) | 52.16 | 63.42 |
| Support Level | $71.00 | $419.81 |
| Resistance Level | $82.45 | N/A |
| Average True Range (ATR) | 2.84 | 13.51 |
| MACD | -0.03 | 1.34 |
| Stochastic Oscillator | 64.50 | 75.93 |
Microchip Technology became an independent company in 1989 when it was spun off from General Instrument. More than half of revenue comes from MCUs, which are used in a wide array of electronic devices from remote controls to garage door openers to power windows in autos. The company's strength lies in lower-end 8-bit MCUs that are suitable for a wider range of less technologically advanced devices, but the firm has expanded its presence in higher-end MCUs and analog chips as well.
Waters sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. In early 2026, Waters merged with Becton Dickinson's life science and diagnostics business, which increased its concentration in diagnostics and discovery-related life science tools.